PL EN


Preferences help
enabled [disable] Abstract
Number of results
1993 | 53 | 1 | 289-296
Article title

Non-opioid peptides for analgesia

Selected contents from this journal
Title variants
Languages of publication
EN
Abstracts
EN
Amongst the <spinal peptide> candidates believed to be involved in the mediation of analgesia, only somatostatin fulfills the criterium of a real analgesia substance. Spinal somatostatin specifically blocks the transmission of painful stimuli. Spinal calcitonin may lower the opioid dose requirement in patients with bone metastases but it fails to relieve acute pain. The usefulness of ACTH and CRF for treatment of pain remains to be established. The role of CCK-8, vasopressin and <neurotensin> is unclear. The contradictory findings on antinociception using simple rodent withdrawl reflex tests (e.g. the tail test), or more complex behavioral tests in which supraspinal sensory processing is involved, (e.g. the hot plate test), indicate that these tests are inappropriate when neuropeptides are employed. Furthermore, due to their inability to predict analgesia in humans, they do not fulfill the guidelines proposed by the IASP that animal test procedured have to be for the benefit of humans.
Publisher

Year
Volume
53
Issue
1
Pages
289-296
Physical description
Contributors
author
author
author
References
Document Type
paper
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-13ba0b57-9e79-33cb-962c-2b6feb0dac16
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.